Axsome Therapeutics (AXSM) Shares Issued (2016 - 2026)

Axsome Therapeutics' Shares Issued history runs 11 years deep, the most recent figure standing at $6.3 million for Q1 2026.

• In Q1 2026, Shares Issued fell 67.72% year-over-year to $6.3 million; the TTM figure through Mar 2026 stood at $54.6 million (up 11.04% YoY), while the FY2025 annual figure was $67.9 million, up 66.5% from the prior year.
• Shares Issued came in at $6.3 million for Q1 2026 at Axsome Therapeutics, up from $5.7 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $243.4 million in Q3 2022 to a low of $176000.0 in Q2 2022.
• A 5-year average of $42.5 million and a median of $11.5 million in 2024 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued slumped 97.02% in 2022 and surged 119956.82% in 2023, its largest moves.
• Axsome Therapeutics' Shares Issued stood at $243.4 million in 2022, then plunged by 86.13% to $33.8 million in 2023, then slumped by 51.35% to $16.4 million in 2024, then sank by 65.44% to $5.7 million in 2025, then climbed by 11.77% to $6.3 million in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $6.3 million, $5.7 million, and $9.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison